Arno Therapeutics, Inc Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-10-29: Reporting owner Kariv Tomer; Form 4; Security 8% Senior Convertible Debenures; Transaction C Conversion of derivative security.
- 2013-06-05: Reporting owner Kariv Tomer; Form 4; Security 8% Senior Convertible Debenures; Transaction Holding.
- 2013-05-07: Reporting owner Kariv Tomer; Form 4; Security 8% Senior Convertible Debenures; Transaction Holding.
- 2013-04-10: Reporting owner Kariv Tomer; Form 4; Security 8% Senior Convertible Debenures; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-10-29 | Kariv Tomer Director | 4 | 8% Senior Convertible Debenures Derivative · Indirect · Pontifax (Israel) II - Individual Investors L.P. | C Conversion of derivative security | −59,558 0 owned after | $2.40 exercise price | 2013-10-31 | |
| 2013-06-05 holding as of filing | Kariv Tomer Director | 4 | 8% Senior Convertible Debenures Derivative · Indirect · (m) | Holding | 476,467 owned after | $0.30 exercise price | 2013-06-05 | |
| 2013-05-07 holding as of filing | Kariv Tomer Director | 4 | 8% Senior Convertible Debenures Derivative · Indirect · (m) | Holding | 476,467 owned after | $0.30 exercise price | 2013-05-07 | |
| 2013-04-10 holding as of filing | Kariv Tomer Director | 4 | 8% Senior Convertible Debenures Derivative · Indirect · (m) | Holding | 476,467 owned after | $0.30 exercise price | 2013-04-10 |